Synopsis
Synopsis
0
JDMF
0
VMF
0
Australia
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Antaxone
2. Celupan
3. En 1639a
4. En-1639a
5. En1639a
6. Nalorex
7. Naltrexone
8. Nemexin
9. Revia
10. Trexan
1. Naltrexone Hcl
2. 16676-29-2
3. Trexan
4. Depade
5. Antaxone
6. Revia
7. Naltrexone (hydrochloride)
8. En-1639a
9. Nih 8503
10. Celupan
11. Nemexin
12. N-cyclopropylmethyl-noroxymorphone Hydrochloride
13. Mls000069607
14. Naltrexone Hydrochloride [usp]
15. Z6375yw9sf
16. Vivitrex
17. 17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-morphinan-6-one Hydrochloride
18. Nalorex
19. Smr000058767
20. En-1639a (as Hydrochloride)
21. En 1639a
22. (4r,4as,7ar,12bs)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride
23. Naltrexone Hydrochloride (usp)
24. (4r,4as,7ar,12bs)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7ah)-one Hydrochloride
25. Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, Hydrochloride (1:1), (5alpha)-
26. Ccris 1168
27. Einecs 240-723-0
28. Unii-z6375yw9sf
29. Naltrel
30. Naltrexone.hcl
31. Naltrexone Depot
32. Prestwick_348
33. Mfcd00069324
34. (5alpha)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride
35. Revia (tn)
36. Xr-ntx
37. (4r,4as,7ar,12bs)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
38. Opera_id_1828
39. Naltrexone Monohydrochloride
40. Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-, Hydrochloride
41. Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, Hydrochloride, (5-alpha)-
42. Schembl37713
43. Mls001076516
44. Mls002153483
45. Mls002695940
46. Cyto-205
47. Chembl1201149
48. Dtxsid50937236
49. Pti-901
50. Chebi:134687
51. Bcp08343
52. Naltrexone Hydrochloride [mi]
53. S2103
54. Vp-004
55. Akos015994597
56. Ccg-268383
57. Cs-0763
58. Hs-0003
59. Nc00693
60. 17-cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride
61. Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-alpha-oxy-3,14-dihydoxy-, Hydrochloride
62. Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, Hydrochloride, (5alpha)-
63. Naltrexone Hydrochloride [mart.]
64. Naltrexone Hydrochloride [vandf]
65. Naltrexone Hydrochloride [who-dd]
66. Bn164635
67. Hy-76710
68. Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, Hydrochloride, (5.alpha.)-
69. N1176
70. Naltrexone Hydrochloride [green Book]
71. Sw196619-3
72. Naltrexone Hydrochloride [orange Book]
73. D02095
74. Embeda Component Naltrexone Hydrochloride
75. H10489
76. Naltrexone Hydrochloride [ep Monograph]
77. Naltrexone Hydrochloride [usp Monograph]
78. Troxyca Component Naltrexone Hydrochloride
79. 676n292
80. Contrave Component Naltrexone Hydrochloride
81. Naltrexone Hydrochloride Component Of Embeda
82. Naltrexone Hydrochloride Component Of Troxyca
83. Naltrexone Hydrochloride Component Of Contrave
84. Q27096434
85. Z1558290144
86. Naltrexone Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
87. Naltrexone Hydrochloride, European Pharmacopoeia (ep) Reference Standard
88. (5a)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-morphinan-6-one Hydrochloride
89. 17-(cyclopropylmethyl)-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one Hydrochloride
90. 17-cyclopropylmethyl)-4,5.alpha.-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride
91. (1s,5r,13r,17s)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one Hydrochloride
92. (4r,4as,7ar,12bs)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydron;chloride
93. (5alpha,17r)-17-(cyclopropylmethyl)-3,14-dihydroxy-6-oxo-4,5-epoxymorphinan-17-ium Chloride
94. Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5.alpha.)-, Hydrochloride (1:1)
Molecular Weight | 377.9 g/mol |
---|---|
Molecular Formula | C20H24ClNO4 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 2 |
Exact Mass | 377.1393859 g/mol |
Monoisotopic Mass | 377.1393859 g/mol |
Topological Polar Surface Area | 70 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 621 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Naltrexone hydrochloride |
PubMed Health | Naltrexone |
Drug Classes | Ethanol Dependency, Opioid Dependency, Toxicology-Antidote Agent |
Drug Label | Naltrexone hydrochloride, an opioid antagonist, is a synthetic congener of oxymorphone with no opioid agonist properties. Naltrexone differs in structure from oxymorphone in that the methyl group on the nitrogen atom is replaced by a cyclopropylmethy... |
Active Ingredient | Naltrexone hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 25mg; 100mg; 50mg |
Market Status | Prescription |
Company | Accord Hlthcare; Mallinckrodt; Sun Pharma Global; Elite Labs; Barr |
2 of 6 | |
---|---|
Drug Name | Revia |
PubMed Health | Naltrexone |
Drug Classes | Ethanol Dependency, Opioid Dependency, Toxicology-Antidote Agent |
Drug Label | REVIA (naltrexone hydrochloride tablets USP), an opioid antagonist, is a synthetic congener of oxymorphone with no opioid agonist properties. Naltrexone differs in structure from oxymorphone in that the methyl group on the nitrogen atom is replaced... |
Active Ingredient | Naltrexone hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Teva Womens |
3 of 6 | |
---|---|
Drug Name | Vivitrol |
Active Ingredient | Naltrexone |
Dosage Form | For suspension, extended release |
Route | Intramuscular |
Strength | 380mg/vial |
Market Status | Prescription |
Company | Alkermes |
4 of 6 | |
---|---|
Drug Name | Naltrexone hydrochloride |
PubMed Health | Naltrexone |
Drug Classes | Ethanol Dependency, Opioid Dependency, Toxicology-Antidote Agent |
Drug Label | Naltrexone hydrochloride, an opioid antagonist, is a synthetic congener of oxymorphone with no opioid agonist properties. Naltrexone differs in structure from oxymorphone in that the methyl group on the nitrogen atom is replaced by a cyclopropylmethy... |
Active Ingredient | Naltrexone hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 25mg; 100mg; 50mg |
Market Status | Prescription |
Company | Accord Hlthcare; Mallinckrodt; Sun Pharma Global; Elite Labs; Barr |
5 of 6 | |
---|---|
Drug Name | Revia |
PubMed Health | Naltrexone |
Drug Classes | Ethanol Dependency, Opioid Dependency, Toxicology-Antidote Agent |
Drug Label | REVIA (naltrexone hydrochloride tablets USP), an opioid antagonist, is a synthetic congener of oxymorphone with no opioid agonist properties. Naltrexone differs in structure from oxymorphone in that the methyl group on the nitrogen atom is replaced... |
Active Ingredient | Naltrexone hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Teva Womens |
6 of 6 | |
---|---|
Drug Name | Vivitrol |
Active Ingredient | Naltrexone |
Dosage Form | For suspension, extended release |
Route | Intramuscular |
Strength | 380mg/vial |
Market Status | Prescription |
Company | Alkermes |
Alcohol Deterrents
Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism. (See all compounds classified as Alcohol Deterrents.)
Narcotic Antagonists
Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-03-17
Pay. Date : 2013-03-11
DMF Number : 20623
Submission : 2007-06-20
Status : Active
Type : II
Certificate Number : CEP 2009-287 - Rev 03
Issue Date : 2024-03-01
Type : Chemical
Substance Number : 1790
Status : Valid
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2019-05-30
Registration Number : 20190530-209-J-359
Manufacturer Name : Sanofi Winthrop Industrie
Manufacturer Address : Route d'Avignon 30390 Aramon, France
Available Reg Filing : CN |
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
NDC Package Code : 52465-103
Start Marketing Date : 2013-12-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Product Not Available For Sales
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-06-16
Pay. Date : 2012-12-20
DMF Number : 15102
Submission : 2000-10-18
Status : Active
Type : II
NDC Package Code : 60870-0395
Start Marketing Date : 1990-01-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
NDC Package Code : 58159-109
Start Marketing Date : 2024-10-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
Certificate Number : R1-CEP 2016-053 - Rev 00
Issue Date : 2023-01-13
Type : Chemical
Substance Number : 1790
Status : Valid
Date of Issue : 2021-08-27
Valid Till : 2024-06-10
Written Confirmation Number : WC-0278
Address of the Firm :
NDC Package Code : 70312-0887
Start Marketing Date : 2015-12-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Registrant Name : Phamchem Service Co., Ltd.
Registration Date : 2023-10-16
Registration Number : 20210611-209-J-542(2)
Manufacturer Name : Rusan Pharma Ltd.
Manufacturer Address : Plot no. 6406, GIDC ESTATE, ANKLESHWAR, City : ANKLESHWAR - 393 002, Dist : Bharuch, Gujarat State, India
Deccan Nutraceuticals: A global leader in the integrated development, manufacturing, and marketing of pharmaceutical products.
NDC Package Code : 45085-0292
Start Marketing Date : 2024-08-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Complete
Rev. Date : 2013-03-17
Pay. Date : 2013-03-11
DMF Number : 20623
Submission : 2007-06-20
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-06-16
Pay. Date : 2012-12-20
DMF Number : 15102
Submission : 2000-10-18
Status : Active
Type : II
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-14
Pay. Date : 2013-12-20
DMF Number : 23325
Submission : 2009-12-01
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-05
Pay. Date : 2012-11-27
DMF Number : 6265
Submission : 1986-04-11
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21820
Submission : 2008-07-17
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-07-16
Pay. Date : 2013-01-28
DMF Number : 23214
Submission : 2009-10-21
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-04-22
Pay. Date : 2021-12-03
DMF Number : 36560
Submission : 2022-03-17
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21217
Submission : 2007-12-28
Status : Active
Type : II
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2019-05-30
Registration Number : 20190530-209-J-359
Manufacturer Name : Sanofi Winthrop Industrie
Manufacturer Address : Route d'Avignon 30390 Aramon, France
Registrant Name : Base Farm Co., Ltd.
Registration Date : 2021-09-30
Registration Number : 20210611-209-J-542(1)
Manufacturer Name : Rusan Pharma Ltd.
Manufacturer Address : Plot no. 6406, GIDC ESTATE, ANKLESHWAR, City : ANKLESHWAR - 393 002, Dist : Bharuch, ...
Registrant Name : Phamchem Service Co., Ltd.
Registration Date : 2023-10-16
Registration Number : 20210611-209-J-542(2)
Manufacturer Name : Rusan Pharma Ltd.
Manufacturer Address : Plot no. 6406, GIDC ESTATE, ANKLESHWAR, City : ANKLESHWAR - 393 002, Dist : Bharuch, ...
Registrant Name : Hiple Co., Ltd.
Registration Date : 2021-06-11
Registration Number : 20210611-209-J-542
Manufacturer Name : Rusan Pharma Ltd.
Manufacturer Address : Plot no. 6406, GIDC ESTATE, ANKLESHWAR, City : ANKLESHWAR - 393 002, Dist : Bharuch, ...
Registrant Name : Lee Sung International Co., Ltd.
Registration Date : 2021-03-31
Registration Number : 20210331-209-J-569
Manufacturer Name : SpecGx LLC
Manufacturer Address : 3600 North Second Street, St, Louis, Missouri 63147, USA
Registrant Name : CTC Bio Co., Ltd.
Registration Date : 2020-09-23
Registration Number : 20200923-209-J-729
Manufacturer Name : Siegfried PharmaChemikalien ...
Manufacturer Address : Karlstraße 15-39, 42-44, 32423 Minden, Germany
Registrant Name : Lee Sung International Co., Ltd.
Registration Date : 2024-10-21
Registration Number : 20241021-209-J-1705
Manufacturer Name : Sun Pharmaceutical Industrie...
Manufacturer Address : Plot No. 24/2 & 25, Phase-IV, GIDC Industrial Zone, AT & Post Panoli-394 116, Distric...
About the Company : Established in 1997, Temad Co. is one of the largest producers of APIs in Iran & an innovative manufacturer of narcotic and non-narcotic products of world-class quality in the Midd...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
About the Company : Faran Shimi Pharmaceutical Company, established in 2001 and affiliated with Golrang Pharmaceutical Investment Co, manufactures high-quality Active Pharmaceutical Ingredients (APIs)...
About the Company : EUROAPI is focused on reinventing active ingredient solutions to meet the needs of customers and patients worldwide sustainably. We are a leading player in APIs with approximately ...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
About the Company : Rusan Pharma is a fully integrated global pharmaceutical company specializing in the treatment of addiction & pain management. We manufacture & market a wide range of APIs & formul...
Deccan Nutraceuticals: A global leader in the integrated development, manufacturing, and marketing of pharmaceutical products.
About the Company : Deccan Nutraceuticals Pvt. Ltd. (DNPL) is a group company of Alkaloids Corporation (India), was founded in 2001 and operates from a 22,000 sq. m. facility in Pune (India). Their co...
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
About the Company : Founded in 1979, Noramco specializes in the development and manufacturing of APIs for both opioid and non-opioid products. With expertise in controlled substance development and ma...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
Regulatory Info :
Registration Country : Iran
Brand Name :
Dosage Form : Capsule
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
Packaging :
Regulatory Info :
Dosage : Capsule
Dosage Strength : 50MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Iran
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 50mg
Packaging : Pack Size 3x10; 2x14; 10x10
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : Pack Size 3x10; 2x14; 10x10
Regulatory Info :
Dosage : Tablet
Dosage Strength : 50mg
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet Implant
Dosage Strength : 765mg
Packaging : Pack Size 2 Tablets in 1 Carton; 1 Tablets in 1 Carton
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : Pack Size 2 Tablets in 1 Carton; 1 Tablets in 1 Carton
Regulatory Info :
Dosage : Tablet Implant
Dosage Strength : 765mg
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : U.S.A
Brand Name :
Dosage Form : Tablet
Dosage Strength : 50MG
Packaging : Size: 30s, 100s
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Packaging : Size: 30s, 100s
Regulatory Info :
Dosage : Tablet
Dosage Strength : 50MG
Brand Name :
Approval Date :
Application Number :
Registration Country : U.S.A
Regulatory Info :
Registration Country : Turkey
Brand Name :
Dosage Form : Capsule
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging :
Regulatory Info :
Dosage : Capsule
Dosage Strength : 50MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Turkey
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
25
PharmaCompass offers a list of Naltrexone Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Naltrexone Hydrochloride manufacturer or Naltrexone Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Naltrexone Hydrochloride manufacturer or Naltrexone Hydrochloride supplier.
PharmaCompass also assists you with knowing the Naltrexone Hydrochloride API Price utilized in the formulation of products. Naltrexone Hydrochloride API Price is not always fixed or binding as the Naltrexone Hydrochloride Price is obtained through a variety of data sources. The Naltrexone Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Antaxone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Antaxone, including repackagers and relabelers. The FDA regulates Antaxone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Antaxone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Antaxone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Antaxone supplier is an individual or a company that provides Antaxone active pharmaceutical ingredient (API) or Antaxone finished formulations upon request. The Antaxone suppliers may include Antaxone API manufacturers, exporters, distributors and traders.
click here to find a list of Antaxone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Antaxone DMF (Drug Master File) is a document detailing the whole manufacturing process of Antaxone active pharmaceutical ingredient (API) in detail. Different forms of Antaxone DMFs exist exist since differing nations have different regulations, such as Antaxone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Antaxone DMF submitted to regulatory agencies in the US is known as a USDMF. Antaxone USDMF includes data on Antaxone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Antaxone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Antaxone suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Antaxone Drug Master File in Korea (Antaxone KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Antaxone. The MFDS reviews the Antaxone KDMF as part of the drug registration process and uses the information provided in the Antaxone KDMF to evaluate the safety and efficacy of the drug.
After submitting a Antaxone KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Antaxone API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Antaxone suppliers with KDMF on PharmaCompass.
A Antaxone CEP of the European Pharmacopoeia monograph is often referred to as a Antaxone Certificate of Suitability (COS). The purpose of a Antaxone CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Antaxone EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Antaxone to their clients by showing that a Antaxone CEP has been issued for it. The manufacturer submits a Antaxone CEP (COS) as part of the market authorization procedure, and it takes on the role of a Antaxone CEP holder for the record. Additionally, the data presented in the Antaxone CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Antaxone DMF.
A Antaxone CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Antaxone CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Antaxone suppliers with CEP (COS) on PharmaCompass.
A Antaxone written confirmation (Antaxone WC) is an official document issued by a regulatory agency to a Antaxone manufacturer, verifying that the manufacturing facility of a Antaxone active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Antaxone APIs or Antaxone finished pharmaceutical products to another nation, regulatory agencies frequently require a Antaxone WC (written confirmation) as part of the regulatory process.
click here to find a list of Antaxone suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Antaxone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Antaxone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Antaxone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Antaxone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Antaxone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Antaxone suppliers with NDC on PharmaCompass.
Antaxone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Antaxone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Antaxone GMP manufacturer or Antaxone GMP API supplier for your needs.
A Antaxone CoA (Certificate of Analysis) is a formal document that attests to Antaxone's compliance with Antaxone specifications and serves as a tool for batch-level quality control.
Antaxone CoA mostly includes findings from lab analyses of a specific batch. For each Antaxone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Antaxone may be tested according to a variety of international standards, such as European Pharmacopoeia (Antaxone EP), Antaxone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Antaxone USP).